Drug of choice in rhinoscleromatosis is:
High-Yield Explanation
In rhinoscleromatosis, organism may be difficult to eradicate, despite aggressive therapy. A combination of conservative surgical debridement and long-term antibiotic coverage is the mainstay of therapy for rhinoscleroma. Tetracycline has been shown to be effective and inexpensive for patients unless contraindicated. Fluoroquinolones may be used as an alternative, given their excellent gram-negative activity and convenient dosing regimen